Contents
ANBITION activities are focused on developing new molecules and technologies useful for treating or diagnosing angiogenesis-related diseases, including eye neo-vascular disease such as macular oedema, wet age-related macular degeneration and diabetic retinopathy.
Timeline
No Timeline data yet.
Further Resources
Title
Author
Link
Type
Date
No Further Resources data yet.
References
Company attributes
Location
Email Address
info@bioviiix.com
davide.rosiello@bioviiix.com
Phone Number
+390812395462
Fax Number
+39 081 2397208
